Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
Background: Hyperfunctional platelets play important roles in thromboembolism in patients with β-thalassaemia/ haemoglobin E (β-thal/HbE). Our previous study revealed ex vivo inhibitory effects of deferiprone on normal platelets. Herein, we aimed to investigate the in vivo effects on platelets in pa...
Saved in:
Main Authors: | Ngan Thi Tran (Author), Pranee Sutcharitchan (Author), Jindaporn Janprasit (Author), Ponlapat Rojnuckarin (Author), Noppawan Phumala Morales (Author), Rataya Luechapudiporn (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effect of Lusianthridin on Hemin-Induced Low-Density Lipoprotein Oxidation
by: Su Wutyi Thant, et al.
Published: (2021) -
Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018) -
A rare case of double heterozygous state for HbD and HbE
by: Sanjeev Kumar Gupta, et al.
Published: (2015) -
Phenotypic diversity in beta-HbE thalassemia patients
by: Pustika Amalia Wahidiyat, et al.
Published: (2016) -
Non-compliance to iron chelation therapy in patients with transfusion-dependent thalassaemia
by: Allen Shiun Chat Chai, et al.
Published: (2021)